LKLitza Kiropoulos

Litza Kiropoulos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Litza Kiropoulos has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Symptoms to Structures: A Systematic Review and Meta-Analysis of Major Depressive Symptom Networks

    by Charles Jack Strathdee, Phuong Linh Dang, Isabel Krug, Litza Kiropoulos, Charles Benjamin Malpas

    Major depressive disorder (MDD) is a leading condition examined using network analysis. However, meta-analytic evidence is limited for MDD symptom network studies. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines, we searched Embase, MEDLINE, PsycINFO, CINAHL and bibliographies of previous literature for articles that have produced MDD symptom networks. After screening, 104 articles (N = 875,852) were included in this review, consisting of 85 cross-sectional and 19 temporal network analysis studies. A random-effects Meta-analytic Gaussian Network Aggregation (MAGNA) of MDD symptom networks was estimated based on available data. Despite a pronounced variation in MDD measures and sample demographics, findings consistently showed that depressed mood and fatigue emerged as the most central symptoms. Collectively, this systematic review and meta-analysis underscores network analysis as a technique for understanding MDD symptom dynamics and one that has the potential to improve psychological interventions. Ongoing efforts toward intensive longitudinal datasets and improved reporting practices represent two key avenues for MDD network analysis research.

  • Open Access

    A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial

    by Litza A. Kiropoulos, Trevor J. Kilpatrick, Tomas Kalincik, Leonid Churilov, Richard Macdonell, Neil Shuey, Tissa Wijeratne

  • Open Access

    Uncertainty Meets Disordered Eating and Body Image: A Transdiagnostic Network Study Across Depressive, Anxiety and Anorexia Nervosa Symptoms Including a Control Group

    by Roser Granero, Isabel Krug, Litza Kiropoulos

    Background and objectives: Intolerance of uncertainty (IU) is a well-established transdiagnostic process in anxiety (ANX) and major depressive disorder (MDD), and has been increasingly implicated in anorexia nervosa (AN). However, most previous research including patients with AN has relied on total or subscale scores from eating disorder measures, which obscures how specific eating attitudes and body dissatisfaction symptoms relate to distinct facets of IU. The primary objective of the present study was to characterize item-level networks linking eating attitudes, body dissatisfaction, and IU in a pooled clinical mental health sample, alongside a control group (CG). Methods: Data were drawn from a sample including individuals with symptoms related to AN (N = 105), MDD (N = 97), and ANX (N = 240), a comorbid group (N = 84) with symptoms of two or more of these conditions, and a CG (N = 842). Separate item-level networks were estimated for clinical and control groups, and network structure and centrality indices were compared. Results: Network analyses revealed distinct organizational patterns between the clinical and control subsamples. Although both networks showed identical diameters, the clinical network exhibited a shorter average path length and higher clustering, indicating stronger local connectivity, whereas the control network showed higher modularity. In the clinical subsample, nodes related to binge eating, post-eating guilt, and IU emerged as the most central and acted as key connectors between clusters. In contrast, the control network displayed a more distributed centrality pattern, suggesting a more integrated and homogeneous network organization. Conclusions: This study provides new evidence to refine our understanding of how IU relates to eating attitudes and body dissatisfaction across diagnostic mental health boundaries. Identifying highly influential psychopathological symptoms across eating, mood, and anxiety disorders, as well as bridge nodes linking these mental health domains, is important for understanding transdiagnostic symptom dynamics. These insights may inform the development of more sensitive screening and diagnostic tools, as well as targeted intervention points to support more personalized and mechanism-focused treatments.


  • Open Access

    Profiles of Emotion Regulation Difficulties in People with Multiple Sclerosis: Associations with Depressive and Anxiety Symptoms

    by Phuong Linh Dang, Isabel Krug, Litza Kiropoulos

    Background: Emotion regulation is a multidimensional construct that is robustly linked to emotional disorders yet remains underexplored in multiple sclerosis (MS), with no studies to date addressing individual differences in emotion regulation difficulties in this population. To address this gap, the current study used latent profile analysis (LPA) to identify distinct profiles of emotion regulation difficulties in an MS sample. Methods: Participants were 259 people with MS ( M age = 42.79, 78.8% female). Participants completed an online survey measuring emotion regulation difficulties and symptoms of depression, generalized anxiety disorder (GAD), health anxiety, and posttraumatic stress disorder (PTSD). Emotion regulation was specified as the indicator variable in the LPA, with the additional measures of depression and anxiety utilized to validate the identified profiles. Results: Three emotion regulation profiles were identified: low impairment (n = 66, 25.48%) characterized by minimal difficulties regulating negative emotions across all domains; global dysregulation (n = 71, 27.41%) characterized by pronounced difficulties in all domains; and goal-impaired regulators (n = 122, 47.10%) characterized by distinct challenges maintaining goal-directed behaviors. Individuals in the global dysregulation profile endorsed the greatest symptom severity on measures of depression and PTSD but reported comparable levels of GAD and health anxiety relative to the goal-impaired regulators . Conclusion: People with MS exhibit distinct patterns of emotion regulation difficulties, revealing critical subgroups with varying psychological needs.

  • Open Access

    A Psychosexual Model of Sexual Functioning in Multiple Sclerosis: The Role of Body-Image Dissatisfaction, Avoidant Attachment, and Sexual Self-Efficacy

    by Rebekah Allison Davenport, Isabel Krug, Litza Kiropoulos

    Background: Sexual difficulties (SDs) are prevalent multiple sclerosis (MS) yet remain underdiagnosed and undertreated, reflecting limited understanding of the psychological factors implicated. Although multidisciplinary models of care are increasingly advocated in MS, psychological interventions for SDs remain scarce. Sexual theory identifies avoidant attachment and internal representations of the body and sexuality as central determinants of sexual functioning. Aim: This study evaluated a novel psychosexual model in which body-image dissatisfaction was modelled as a predictor of domain-specific functions, mediated by lower sexual self-efficacy and higher avoidant attachment. Outcomes: Sexual interest, satisfaction, and orgasmic functioning domains were measured by PROMIS® Sexual Function and Satisfaction Brief Profile v2.0. Methods: A population-based cohort of 198 individuals with MS completed a cross-sectional survey, including 147 cisgender individuals reporting recent sexual activity (36 men; 111 women). Path analysis examined direct associations between body-image dissatisfaction and sexual interest, satisfaction, and orgasmic functioning, and indirect effects via avoidant attachment and sexual self-efficacy. Gender and gait-disability were included as covariates. A post-hoc sensitivity restricted to women evaluated the stability of structural pathways following the exclusion of men.Results: Body-image dissatisfaction predicted lower sexual self-efficacy (ß= -.20, p<.05, 95%CI: -.39, -.02) but not avoidant attachment or sexual function outcomes. Avoidant attachment predicted sexual interest (ß= -.22, p<.05, 95%CI: -.43, -.02), while sexual self-efficacy demonstrated medium-to-large associations across outcomes, with the largest for satisfaction (ß=.59, p<.0001, 95%CI: .37, .81). The model demonstrated excellent fit. Post-hoc sensitivity analyses suggested that findings are robust to the exclusion of men participants. Clinical Implications: Avoidant attachment and sexual self-efficacy are potentially important treatment targets. Higher avoidant attachment is relevant to diminished sexual interest, possibly reflecting a suppression of approach-oriented motivation that underpins spontaneous interest. Sexual self-efficacy is a more ubiquitous factor related to SDs. Strengths and Limitations: This is the first study to propose a psychological model of sexual functioning in MS, and examine the role of body-image dissatisfaction, avoidant attachment, and sexual self-efficacy in predicting sexual functioning outcomes in this population. The modest sample size precluded the use of multi-group path analysis to formally evaluate gender-related variation in pathways. Larger, gender-balanced samples are needed. Future research should further delineate the effects of body-image on sexual functioning. Conclusions: Avoidant attachment and sexual self-efficacy are potentially important targets for interventions targeting SDs in MS.

  • Open Access

    Psychometric Evaluation of The PROMIS v2.0 Brief Profile Gender-inclusive Sexual Function Domains in Multiple Sclerosis

    by Rebekah Allison Davenport, Isabel Krug, Litza Kiropoulos

    Background: Sexual difficulties (SDs) are prevalent in multiple sclerosis (MS) yet remain underdiagnosed and undertreated, reflecting limited validated assessment tools. The PROMIS® Sexual Function and Satisfaction (SexFS) Brief Profile v2.0 includes gender-inclusive subscales assessing sexual interest, satisfaction, and orgasmic functioning. Aim: Evaluate the psychometric properties of the SexFS gender-inclusive domains in a sample of adults living with MS. Methods: A population-based cohort of 198 MS individuals completed a cross-sectional survey, of whom 147 reported recent sexual activity (men n= 36; women n= 111). Psychometric evaluation examined data quality (score distribution, floor/ceiling effects), internal consistency (Cronbach α), convergent and divergent validity via Spearman rank-order correlations, and structural validity through factor analyses. Outcomes: Sexual interest, satisfaction with sex life, and orgasmic function. Results: Item responses showed good distributional properties, strong item–total correlations, and high scaling success. Factor analyses supported the original higher-order three-domain SexFS structure with acceptable model fit. Orgasmic function was represented as a unidimensional domain despite minor local estimation instability. Construct validity was supported by expected correlation patterns, including moderate associations with sexual self-efficacy (.32-.53). Internal consistency was strong across domains (α range: .74-.89). Gender effects on the latent sexual function domains were small and non-significant when modelled as exogenous covariates.Clinical implications: Findings support the SexFS gender-inclusive domains as valid and reliable measures in adult men and women living with MS. By enabling gender-inclusive, domain-specific assessment, the SexFS represents an important advance in the MS sexual health literature, allowing meaningful comparison of sexual functioning across genders within the MS population and other disease groups.Strengths and Limitations: The SexFS assesses domain-specific sexual function in MS, including sexual interest regardless of sexual activity. Men were underrepresented in the sample, limiting precision and generalisability of estimates for men with MS. Establishing the psychometric properties of gender-specific SexFS domains is a priority for future research to support comprehensive assessment in MS. Conclusions: Findings support the SexFS gender-inclusive domains as valid and reliable measures in an adult MS sample. Keywords: Multiple sclerosis; Sexual function; Sexual interest; Sexual satisfaction; Orgasm; Patient-reported outcome measures; SexFS

  • Open Access

    Factor structure and psychometric properties of the Intolerance of Uncertainty Scale-12 (IUS-12) in multiple sclerosis

    by Phuong Linh Dang, Isabel Krug, Litza Kiropoulos

    Intolerance of uncertainty (IU) is a transdiagnostic risk factor that has been robustly implicated in several internalising psychopathologies, particularly depression and anxiety. Although emerging evidence emphasises the presence and impact of IU in multiple sclerosis (MS), it is unclear whether current measures of IU are appropriate for people with MS. In this study, we describe the psychometric features of the short-form Intolerance of Uncertainty Scale (IUS-12) in a mixed sample of 2117 participants (244 MS, 1873 non-MS controls). Specific aims were to (i) assess the internal reliability and dimensionality of the IUS-12; (ii) test measurement invariance across MS and non-MS groups; and (iii) determine construct validity by correlating the IUS-12 with measures of psychological distress and anxiety, test-retest reliability and temporal stability over a six-month interval, and clinical utility of the IUS-12 in detecting clinically significant symptoms of generalised anxiety disorder, posttraumatic stress disorder, and health anxiety. A bifactor model, comprising a General IU factor and two group factors (Prospective IU and Inhibitory IU), best represented the IUS-12. Measurement invariance was found across MS and non-MS participants. The IUS-12 had good construct validity and moderate test-retest reliability (intraclass correlation coefficient [ICC] = .62) over the six-month survey period. Given the central role of uncertainty in the lived experience of MS, these findings support the use of the IUS-12 as a psychometrically sound measure of IU in this population. Routine assessment incorporating the IUS-12 may help inform the development of targeted psychological interventions for people with MS.

  • Open Access

    Profiles of emotion regulation in multiple sclerosis: Associations with depressive and anxiety symptoms

    by Phuong Linh Dang, Isabel Krug, Litza Kiropoulos

    Background. Emotion regulation is a multidimensional construct that is robustly linked to emotional disorders yet remains underexplored in multiple sclerosis (MS), with no studies to date addressing individual differences in emotion regulation difficulties in this population. To address this gap, the current study used latent profile analysis (LPA) to identify distinct profiles of emotion regulation difficulties in an MS sample. Methods. Participants were 259 people with MS (Mage = 42.79, 78.8% female). Participants completed an online survey measuring emotion regulation difficulties and symptoms of depression, generalised anxiety disorder (GAD), health anxiety, and posttraumatic stress disorder (PTSD). Emotion regulation was specified as the indicator variable in the LPA, with the additional measures of depression and anxiety utilised to validate the identified profiles.Results. Three emotion regulation profiles were identified: low impairment (n = 66, 25.48%) characterised by minimal difficulties regulating negative emotions across all domains; global dysregulation (n = 71, 27.41%) characterised by pronounced difficulties in all domains; and goal-impaired regulators (n = 122, 47.10%) characterised by distinct challenges maintaining goal-directed behaviours. Individuals in the global dysregulation profile endorsed the greatest symptom severity on measures of depression and PTSD but reported comparable levels of GAD and health anxiety relative to the goal-impaired regulators.Conclusion. People with MS exhibit distinct emotion regulation profiles, revealing critical subgroups with varying psychological needs. Tailoring psychological assessments and treatments to these profiles can enhance the management of depression and anxiety and potentially improve disease outcomes in people with MS.